CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guided Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guided Therapeutics Inc
Suite 300, 4955 Avalon Ridge Pkwy
Phone: (770) 242-8723p:770 242-8723 NORCROSS, GA  30071  United States Ticker: GTHPGTHP

On 9/25/2017, Guided Therapeutics Inc filed a Registration Withdrawal Request of its Form S-1 (File No. 333-212384) with the SEC. The Company is seeking withdrawal of the Registration Statement because it has decided not to proceed with the offering at this time.

Business Summary
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on the development of medical devices. The Company develops prototypes and conducts limited clinical studies using its biophotonic technology for the detection of esophageal cancer. Its primary focus is selling and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide an alternative to conventional tests for cervical cancer screening and detection. It is focused on two primary applications for LuViva: first, as a cancer screening tool and second, as a triage for various traditional screening.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Michael C.James 65 10/15/2013 3/19/2007
President, Chief Executive Officer, Acting Chief Financial Officer, Chief Operating Officer, Direct Mark L.Faupel 67 3/6/2023 4/1/2001
Acting Chief Financial Officer Gene S.Cartwright 68 3/3/2023 1/7/2014
3 additional Officers and Directors records available in full report.

Business Names
Business Name
GTHP
GTHPD
GTHPE
InterScan, Inc.

General Information
Number of Employees: 6 (As of 12/31/2022)
Outstanding Shares: 52,096,121 (As of 11/9/2023)
Shareholders: 174
Stock Exchange: OTC
Federal Tax Id: 582029543
Fax Number: (770) 242-8639
Email Address: Iskillen@spectrx.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024